Skip to main content
. 2020 Oct 20;157:103123. doi: 10.1016/j.critrevonc.2020.103123

Table 2.

Summary of the main pooled effect estimates (95 % CI) of studies comparing mHealth to control with data on at least the treatment arm, stratified by 1) questionnaire type and 2) intervention type.

Questionnaire type Pooled effect estimate for HRQoL Studies reporting data on at least the treatment arm; # of studies I2%; P-heterogeneity
EORTC QLQ-C30 (Overall)* Mean difference (95 % CI) 8.48 (4.16, 12.8); n = 9 92.3 %; p < 0.01
By mHealth intervention type:
 Cognitive 11.9 (2.76, 21.0); n = 2 96.0%; p < 0.01
 PA/ fitness 7.05 (1.47, 12.6); n = 5 94.0 %; p < 0.01
 Social support 9.06 (-1.29, 19.4); n = 2 p- 86.8 %; p < 0.01
 p-interaction int:0.67
SF-36 (Overall)* Mean difference (95 % CI) 15.4 (5.30, 25.5); n = 3 88.0%; p < 0.01
By mHealth intervention type:
 Cognitive 13.2 (0.73, 25.7); n = 2 89.9%; p < 0.01
 PA/ fitness 19.5 (2.35, 36.7); n = 1 NA
 p-interaction p-int: 0.56
FACT-G (Overall) Mean difference (95 % CI) −0.03 (-0.19, 0.13); n = 4 85.9 %; p < 0.01
By mHealth intervention type:
 Cognitive Mindfulness 0.04 (-0.31, 0.38); n = 1 NA
 PA/ fitness 0.30 (-0.02, 0.62); n = 1 NA
 Weight management −0.11 (-0.43, 0.21); n = 1−0.32 (-0.63, -0.01); n = 1 NA
 p-interaction p-int:0.05 NA

CI: confidence interval; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; FACT-G: Functional Assessment of Cancer Therapy-General; HRQol: Health-related quality of life; NA: not applicable; SF-36: Medical Outcomes Study 36-Item Short Form.